|
- JAN 15
- Tesshi Yamada (Pathology Division)
Molecular and cellular changes of colorectal cancer cells following the suppression of b-catenin/TCF4-mediated gene transactivation
- Koichi Benjamin Ishikawa (Cancer Information and Epidemiology Division)
Integration of NCC patient data resources for basic and clinical research
- FEB 19
- Takashi Kanazawa (Cancer Prevention Division)
Biological characteristics of pierisin-1, a putative ADP-ribosylating toxin from cabbage butterfly
Yoshinori Murakami (Tumor Suppression & Functional Genomics Project)
Quantitative analysis of allele specific expression by the RNA difference plot
- MAR 19
- Kazuki Sasaki (Growth Factor Division)
A mass spectrometric approach to profiling of peptides secreted by cancer cells
Tomoyuki Yokose (Pathology Division, East)
Morphological and molecular biological analysis of atypical adenomatous hyperplasia-bronchioloalveolar carcinoma sequence of the lung
- APR 16
- Naoko Watanabe (Carcinogenesis Division)
Single nucleotide instability: increase of point mutation rate without microsatellite instability
Kazuhiro Matsuda (Virology and Glycobiology Division)
Dynamics of ganglioside GM3-enriched functional microdomains
- MAY 21
- Yoshinori Ikarashi (Pharmacology Division)
Regulation of NKT cell activation process by dendritic cells
Kouji Maruyama (Growth Factor Division)
Dendritic cell-based immunotherapy against intractable cancers
- JUN 18
- Satoru Yamaguchi (Biology Division)
A single nucleotide polymorphism at the splice donor site of the human MYH base excision repair gene results in reduced translation efficiency of its transcripts
Issay Kitabayashi (Chromatin Function in Leukemogenesis Project/Cancer Genomics Division)
Regulation of AML1 and p53 by histone acetyltransferase MOZ and MOZ-CBP
- JUL 16
- Tomotaka Sobue (Cancer Information and Epidemiology Division)
Current issues on risk factor for lung cancer
Hiroyuki Yonou (Pathology Division, East)
Establishment of a novel species- and tissue-specific metastasis model of human prostate cancer in humanized NOD/SCID mice engrafted with human adult lung and bone
- SEP 17
- Takashi Kohno (Biology Division)
Molecular mechanism for chromosome 9 deletions in lymphoid leukemia
Yoichiro Matsuoka (Experimental Pathology and Chemotherapy Division)
Analysis of high susceptibility to mammary carcinogenesis of human c-Ha-ras proto-oncogene transgenic rat
- OCT 15
- Kazuyoshi Kato (Investigative Treatment Division)
Constitutive tolerance of pancreatic cancer cells to nutrient deprivation: New target for pancreatic cancer therapy
Kazutsune Yamagata (Cancer Genomics Division)
The model system of chromosomal aberration induced by topoisomerase II inhibitor VM-26
- NOV 19
- Yukari Totsuka (Cancer Prevention Division)
Biological activities of aminophenylnorharman (APNH), formed from norharman with aniline
Naganari Ohkura (Growth Factor Division)
The EWS/NOR1 fusion gene product gains a novel activity affecting pre-mRNA splicing
|
|
